Last reviewed · How we verify
NCT06762509: WD
The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease
trial testing Botulinum toxin type A in Wilson Disease in 60 participants. Completed in 1 January 2024.
1 December 2023
Quick facts
| Lead sponsor | The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 December 2016 |
| Primary completion | 1 December 2023 |
| Estimated completion | 1 January 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Botulinum toxin type A (BOTULINUM TOXIN TYPE A) — full drug profile →
Conditions studied
- Wilson Disease — all drugs for Wilson Disease →
Sponsor
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Who can join
Adults 15 to 65, any sex, with Wilson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In order to expand the treatment of Wilson disease and improve the quality of life of patients with Wilson's disease, the clinical effect of botulinum toxin type A injection on Wilson's disease was discussed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06762509
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Botulinum toxin type A
Trials testing the same drug.
- NCT07236632 — Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized S · NA · not yet recruiting
- NCT06448676 — Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides · Phase 4 · not yet recruiting
- NCT06296082 — Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke Sp · Phase 2, PHASE3 · recruiting
- NCT06385171 — Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation · recruiting
- NCT06465056 — Use of Botulinum Toxin A in Direct Eyebrow Lift Scar · Phase 2 · recruiting
Other recruiting trials for Wilson Disease
Currently open trials in the same condition.
- NCT07301216 — Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study · recruiting
- NCT06430359 — Circadian Variation of Urinary Copper Excretion in Wilson Disease Patients · recruiting
- NCT06650319 — A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease · EARLY_PHASE1 · recruiting
- NCT06573723 — Institutional Registry of Rare Diseases · recruiting
- NCT03334292 — Natural History of Wilson Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06762509 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
- Last refreshed: 15 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06762509.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing